CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 25,000 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 2,500 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 2,543 shares (to pay taxes)
- 4 Option exercise Director acquired 750 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Option exercise Director acquired 750 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 3,342 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 5 of 49 · 965 filings